We are live on ! Find out more
HPTX

HYPERION THERAPEUTICS INC COM STK (DE)
HPTX

Delisted

HPTX was delisted on the 7th of May, 2015.

61 hedge funds and large institutions have $295M invested in HYPERION THERAPEUTICS INC COM STK (DE) in 2013 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 23 increasing their positions, 17 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 17

0% more funds holding

Funds holding: 6161 (0)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

0% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 12

17% less capital invested

Capital invested by funds: $353M → $295M (-$58.8M)

Holders
61
Holders Change
Holders Change %
0%
% of All Funds
1.77%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.12%
New
12
Increased
23
Reduced
17
Closed
12
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
NMC
1
NEA Management Company
Maryland
$58.3M
Wellington Management Group
2
Wellington Management Group
Massachusetts
$52.6M +$4.34M +184,551 +8%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$51.6M -$10.7M -455,273 -15%
HMPV
4
Highland Management Partners VII
Massachusetts
$39.6M +$46.1M +1,959,520 New
GPP
5
Great Point Partners
Connecticut
$16.4M -$231K -9,793 -1%
CCM
6
Consonance Capital Management
New York
$14.8M +$15.3M +651,154 +783%
Vanguard Group
7
Vanguard Group
Pennsylvania
$5.63M +$870K +36,952 +15%
Franklin Resources
8
Franklin Resources
California
$5.56M -$98.9K -4,200 -2%
JP Morgan Chase
9
JP Morgan Chase
New York
$4.82M -$294K -12,475 -5%
Wells Fargo
10
Wells Fargo
California
$4.66M +$5.13M +218,093 +1,774%
BFA
11
BlackRock Fund Advisors
California
$4.6M -$5.41M -229,741 -50%
Allianz Asset Management
12
Allianz Asset Management
Germany
$2.64M
State Street
13
State Street
Massachusetts
$2.41M +$461K +19,576 +20%
RHJA
14
Rice Hall James & Associates
California
$2.37M +$860K +36,540 +45%
Northern Trust
15
Northern Trust
Illinois
$2.34M +$13.6K +576 +0.5%
AllianceBernstein
16
AllianceBernstein
Tennessee
$2.28M -$10.5M -444,982 -80%
RPAM
17
Rhenman & Partners Asset Management
Sweden
$2.22M +$2.59M +110,000 New
VM
18
VHCP Management
New York
$2.21M -$2.55M -108,300 -50%
BIT
19
BlackRock Institutional Trust
California
$1.8M -$43.6K -1,854 -2%
AIS
20
AlphaOne Investment Services
Pennsylvania
$1.78M +$146K +6,222 +8%
MSA
21
Mason Street Advisors
Wisconsin
$1.71M
TG
22
TCW Group
California
$1.27M -$462K -19,637 -24%
PAI
23
Palo Alto Investors
California
$1.27M
A
24
Abingworth
United Kingdom
$1.26M
Bank of New York Mellon
25
Bank of New York Mellon
New York
$721K +$135K +5,756 +19%

HPTX Hedge Fund Activity: Q4 2013 in Review

61 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) for Q4 2013, worth a combined $295M — down 17% from $353M a quarter earlier.

Fund positioning in HPTX was balanced in Q4 2013: 12 funds opened new positions, 12 closed out, 23 added to existing stakes and 17 trimmed.

The largest buyer was Consonance Capital Management, adding an estimated $15.3M. The largest seller was RA Capital Management, exiting entirely with an estimated $23.6M sold.

  • 61 institutional investors held HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) as of Q4 2013, unchanged from Q3 2013.
  • Funds reported $295M of HYPERION THERAPEUTICS INC COM STK (DE) stock for Q4 2013, down 17% quarter-over-quarter.
  • 12 funds opened new HYPERION THERAPEUTICS INC COM STK (DE) positions in Q4 2013 and 12 closed out, a net change of 0 holders.
  • The largest HYPERION THERAPEUTICS INC COM STK (DE) buyer in Q4 2013 was Consonance Capital Management, an estimated $15.3M added.
  • The largest HYPERION THERAPEUTICS INC COM STK (DE) seller in Q4 2013 was RA Capital Management, an estimated $23.6M sold.

Based on aggregated 13F filings for Q4 2013.